UP!
| 2016-04-21 | Reiterated Rating | Roth Capital | Buy | |
| 2016-04-05 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2016-04-05 | Lower Price Target | Roth Capital | Buy | $44.00 to $39.00 |
| 2016-04-05 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | |
| 2016-03-01 | Reiterated Rating | Roth Capital | Buy | |
| 2016-01-20 | Reiterated Rating | Roth Capital | Buy | |
| 2016-01-12 | Lower Price Target | Roth Capital | Buy | $53.00 to $50.00 |
| 2015-12-16 | Reiterated Rating | Roth Capital | Buy | |
| 2015-10-22 | Reiterated Rating | Roth Capital | Buy | $51.00 to $53.00 |
| 2015-10-15 | Reiterated Rating | Roth Capital | Buy | $51.00 to $53.00 |
| 2015-09-10 | Reiterated Rating | Roth Capital | Buy | |
| 2015-07-23 | Boost Price Target | Roth Capital | Buy | $45.00 to $51.00 |
| 2015-07-15 | Reiterated Rating | Roth Capital | Buy | |
| 2015-04-22 | Set Price Target | Roth Capital | Buy | $42.00 to $45.00 |
| 2015-03-27 | Set Price Target | Roth Capital | Buy | $42.00 |
| 2015-01-26 | Set Price Target | Roth Capital | Buy | $42.00 |
| 2015-01-06 | Set Price Target | Roth Capital | Buy | $36.00 to $42.00 |
| 2014-10-22 | Reiterated | ROTH Capital | Buy | $33 to $36 |
| 2014-10-22 | Boost Price Target | Roth Capital | Buy | $33.00 to $36.00 |
| 2013-11-26 | Boost Price Target | Raymond James | $21.00 to $25.00 | |
| 2013-10-25 | Boost Price Target | Roth Capital | Buy | $15.00 to $22.00 |
| 2011-09-01 | Initiated | Stifel Nicolaus | Hold | |
| 2009-07-13 | Initiated | Cowen & Co | Neutral | |
| 2009-06-03 | Reiterated | Roth Capital | Buy | $10.50 to $12.50 |
| 2009-05-01 | Upgrade | William Blair | Mkt Perform to Outperform | |
| 2009-05-01 | Upgrade | Needham | Hold to Buy | |
| 2009-04-06 | Reiterated | Roth Capital | Buy | $12.50 to $10.50 |
| 2009-01-21 | Reiterated | Roth Capital | Buy | $21 to $12.50 |
| 2009-01-20 | Reiterated | Avondale | Mkt Perform | $17 to $10.50 |
| 2009-01-09 | Reiterated | UBS | Buy | $20 to $16 |
| 2009-01-09 | Reiterated | Stanford Research | Buy | $20 to $16 |
| 2008-12-19 | Initiated | William Blair | Mkt Perform | |
| 2008-09-24 | Downgrade | Needham | Buy to Hold | |
| 2008-09-04 | Reiterated | Roth Capital | Buy | $26 to $28 |
| 2008-09-03 | Reiterated | Roth Capital | Buy | $26 to $28 |
| 2008-08-01 | Reiterated | Roth Capital | Buy | $25 to $26 |
| 2008-07-14 | Downgrade | Avondale | Mkt Outperform to Mkt Perform | $24 |
| 2008-05-02 | Reiterated | Roth Capital | Buy | $22 to $25 |
| 2008-05-01 | Reiterated | Avondale | Mkt Outperform | $22 to $24 |
| 2008-02-12 | Upgrade | Avondale Partners | Mkt Perform to Mkt Outperform | $20 to $22 |
| 2008-02-01 | Initiated | Avondale Partners | Mkt Perform | $20 |
| 2016-04-21 | Reiterated Rating | Roth Capital | Buy | |
| 2016-04-05 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2016-04-05 | Lower Price Target | Roth Capital | Buy | $44.00 to $39.00 |
| 2016-04-05 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | |
| 2016-03-01 | Reiterated Rating | Roth Capital | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In BABY 150 funds of 2208 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 5.73M |
| Vanguard Group, Inc | 2.79M |
| BlackRock Fund Advisors | 2.69M |
| VICTORY CAPITAL MANAGEMENT INC | 2.03M |
| STATE STREET CORP | 1.32M |
| WELLS FARGO & CO/MN | 1.28M |
| DIMENSIONAL FUND ADVISORS LP | 1.24M |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1.15M |
| HENDERSON GROUP PLC | 1.14M |
| WELLINGTON MANAGEMENT CO LLP | 0.89M |
| BlackRock Institutional Trust Company, N.A. | 0.86M |
| PAX WORLD MANAGEMENT LLC | 0.84M |
| RENAISSANCE TECHNOLOGIES LLC | 0.83M |
| Invesco Ltd. | 0.73M |
| GOLDMAN SACHS GROUP INC | 0.70M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| HAWKINS JAMES B Chief Executive Officer | 1.98% (639257) | BABY / DRAD / IRIX / IRMD / OSIS / |
| CHUNG DONG CHUNE CHRISTOPHER Vice President Medical Affairs | 0.42% (136373) | BABY / |
| MURPHY STEVEN J Vice President Finance and CFO | 0.35% (113292) | BABY / |
| TRAVERSO KENNETH M VP Marketing and Sales | 0.34% (109855) | BABY / |
| Kennedy Jonathan Sr. VP, CFO | 0.33% (107588) | BABY / IRMD / ISIL / |
| Buhler John T President and COO | 0.31% (100610) | BABY / |
| LUDLUM KEN | 0.28% (89825) | BABY / CDNA / |
| MOORE WILLIAM M | 0.28% (89402) | BABY / CMD / IRIX / ULGX / |
| Noll Austin Francis III VP/GM Neurology | 0.25% (81901) | BABY / |
| MINCE WILLIAM L Vice President Operations | 0.21% (67162) | BABY / |
| GUNST ROBERT A | 0.17% (55850) | BABY / |
| MICHAEL MARK D | 0.14% (45000) | BABY / |
| Engibous Doris | 0.07% (21750) | BABY / |
| McDonnell Leslie L VP/GM Newborn Care | 0.05% (16836) | BABY / |
| PAUL BARBARA R | 0.02% (7460) | BABY / QHC / |
Undercovermarket.com